6F76
Antibody derived (Abd-8) small molecule binding to KRAS.
6F76 の概要
| エントリーDOI | 10.2210/pdb6f76/pdb |
| 分子名称 | GTPase KRas, MAGNESIUM ION, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, ... (5 entities in total) |
| 機能のキーワード | abd-8, inhibitor, kras, oncoprotein |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 122952.16 |
| 構造登録者 | Bery, N.,Cruz-Migoni, A.,Quevedo, C.E.,Phillips, S.V.E.,Carr, S.,Rabbitts, T.H. (登録日: 2017-12-07, 公開日: 2018-08-08, 最終更新日: 2024-05-08) |
| 主引用文献 | Bery, N.,Cruz-Migoni, A.,Bataille, C.J.,Quevedo, C.E.,Tulmin, H.,Miller, A.,Russell, A.,Phillips, S.E.,Carr, S.B.,Rabbitts, T.H. BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. Elife, 7:-, 2018 Cited by PubMed Abstract: The RAS family of proteins is amongst the most highly mutated in human cancers and has so far eluded drug therapy. Currently, much effort is being made to discover mutant RAS inhibitors and in vitro screening for RAS-binding drugs must be followed by cell-based assays. Here, we have developed a robust set of bioluminescence resonance energy transfer (BRET)-based RAS biosensors that enable monitoring of RAS-effector interaction inhibition in living cells. These include KRAS, HRAS and NRAS and a variety of different mutations that mirror those found in human cancers with the major RAS effectors such as CRAF, PI3K and RALGDS. We highlighted the utility of these RAS biosensors by showing a RAS-binding compound is a potent pan-RAS-effector interactions inhibitor in cells. The RAS biosensors represent a useful tool to investigate and characterize the potency of anti-RAS inhibitors in cells and more generally any RAS protein-protein interaction (PPI) in cells. PubMed: 29989546DOI: 10.7554/eLife.37122 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






